HEPATITIS A VIRUS (HAV) IGM

The Hepatitis A Virus (HAV) IgM Antibody Test is a laboratory blood test that detects Immunoglobulin M (IgM) antibodies produced by the immune system during the early stages of Hepatitis A Virus (HAV) infection. It is the preferred laboratory test for diagnosing acute or recent hepatitis A infection.

Hepatitis A is a contagious viral infection that primarily affects the liver. It spreads through the fecal-oral route, usually by consuming contaminated food or water or through close personal contact with an infected individual. Unlike hepatitis B and hepatitis C, hepatitis A does not cause chronic liver disease, and most people recover completely with lifelong immunity.

Symptoms of acute hepatitis A typically appear 2–7 weeks after exposure and may include fever, fatigue, nausea, vomiting, abdominal pain, loss of appetite, dark urine, pale stools, jaundice (yellowing of the skin and eyes), and itching. Some individuals, particularly young children, may have mild symptoms or remain asymptomatic.

During the early phase of infection, the immune system produces HAV IgM antibodies, which usually become detectable shortly before symptoms develop and remain positive for approximately 3 to 6 months. Their presence strongly suggests a current or recent hepatitis A infection. As the infection resolves, IgM antibodies gradually disappear while HAV IgG antibodies develop and provide long-term immunity.

Doctors commonly recommend the HAV IgM Antibody Test for patients with symptoms of acute hepatitis, abnormal liver function tests, unexplained jaundice, or known exposure to hepatitis A. The test is interpreted together with liver function tests, clinical findings, and the patient's exposure history.

Benefits of the Test

• Detects acute or recent hepatitis A infection.
• Helps diagnose viral hepatitis early.
• Identifies the immune response during active infection.
• Supports prompt medical evaluation and treatment.
• Assists in outbreak investigations and contact tracing.
• Requires only a simple blood sample.
• Highly reliable when performed during the acute phase of illness.
• Supports timely public health interventions.

Why Doctors Recommend This Test

Doctors recommend the HAV IgM Antibody Test when patients have symptoms suggestive of acute hepatitis, including jaundice, fatigue, abdominal pain, nausea, or abnormal liver function tests. It is also recommended after known exposure to hepatitis A or during outbreaks to confirm recent infection.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless advised otherwise by your healthcare provider. Inform your doctor about recent travel, possible exposure to hepatitis A, vaccination history, medications, or liver disease. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 1–3 Working Days

Reporting time may vary depending on laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected acute hepatitis.
• Patients with jaundice.
• People with abnormal liver function tests.
• Individuals with nausea, vomiting, and abdominal pain.
• Patients exposed to someone with hepatitis A.
• Travelers returning from areas with hepatitis A outbreaks.
• Food handlers during outbreak investigations.
• Healthcare workers after suspected exposure.
• Patients referred by liver or infectious disease specialists.
• Anyone advised by their healthcare provider.